Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Baxter International Inc. (NYSE:BAX) said both 200 and 400 mg/kg doses of IV Gammagard Liquid 10% given every two weeks missed the co-primary endpoints in
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury